Vanda Pharmaceuticals Inc. of WASHINGTON, DC filed a DEF 14A with the SEC on 2024-04-29. Industry: Pharmaceutical Preparations.
Showing 15 of 18 documents.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | PROXY STATEMENT |
| 2 | EX-101.SCH | XBRL SCHEMA FILE |
| 3 | EX-101.DEF | XBRL DEFINITION FILE |
| 4 | EX-101.LAB | XBRL LABEL FILE |
| 5 | EX-101.PRE | XBRL PRESENTATION FILE |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 11 | GRAPHIC | GRAPHIC |
| 12 | GRAPHIC | GRAPHIC |
| 13 | GRAPHIC | GRAPHIC |
| 14 | GRAPHIC | GRAPHIC |
| 15 | GRAPHIC | GRAPHIC |
Showing 12 of 44 filings.
| Filed | Form |
|---|---|
| 2026-04-23 | DEFA14A |
| 2026-04-23 | DEF 14A |
| 2025-05-27 | DEFA14A |
| 2025-04-25 | DEFA14A |
| 2025-04-25 | DEF 14A |
| 2024-05-13 | DEFA14A |
| 2024-05-09 | DEFA14A |
| 2024-04-29 | DEF 14A |
| 2023-04-24 | DEFA14A |
| 2023-04-24 | DEF 14A |
| 2022-04-25 | DEFA14A |
| 2022-04-25 | DEF 14A |